Hammel Neurorehabilitation and Research Center
Hammel, Denmark
NCT Number: NCT00612300
The objective of this study is to investigate the effects of an automatic gait trainer (Lokomat) handled by physical therapists compared with categorized gait training by physical therapists in ambulatory stroke patients. Gait speed, gait distance and gait symmetry are used to evaluate study effects.
Hypotheses: 1) The Lokomat improves stroke patients gait speed, distance and symmetry more than categorized gait training.
Looking for future studies?
Notify Me30 year–80 year
All sexes
Interventional
Early Phase 1
Hammel, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A: Lokomat training, 30 minutes per day for 3 weeks, 5 days per week. B: Categorized gait training by physical therapist, 30 minutes per day for 3 weeks, 5 days per week
B: Daily 30 minutes of gait training with a physical therapist, 5 days per week for 3 weeks.
A: Daily 30 minutes of Lokomat training, 5 days per week for 3 weeks.
Time frame: at inclusion, week 3 and week 6
Time frame: Inclusion, wek 3 and week 6
Time frame: Inclusion, week 3 and week 6
Time frame: Inclusion, Week 3 and Week 6
University of Aarhus
Other
The Lokomat Gait Orthosis Compared to Categorized Gait Training by Physical Therapists in Patients Early Post Stroke
Acronym: GTS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00950521
Brain Diseases, Brain Infarction
Taichung, Taiwan
View Trial DetailsNCT07616622
Brain Diseases, Brain Infarction
Faisalābad, Punjab Province, Pakistan
View Trial DetailsNCT01758614
Brain Diseases, Brain Infarction
Beijing, Beijing Municipality, China
View Trial DetailsNCT01468064
Brain Diseases, Brain Infarction
Guangzhou, Guangdong, China
View Trial Details